Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

Benjamin Davis, Ph.D.

University of California, Davis # of Grants: 1


Novel treatments for COPD with Statins 2009 (Cycle 18) $269,523
Pulmonary Disease New Investigator Awards

Anti-inflammatory effects of soluble epoxide hydrolase inhibition are independent of luekicyte recruitment.
Periodical: Biochemical and Biophysical Research Communications Index Medicus:
Authors: Davis, B; Lui, JY; Tancredi, DJ; Wang, L; Simon,S; Hammock, B; Pinkerton, KE ART
Yr: 2011 Vol: Nbr: Abs: Pg:

A Potent Soluble Epoxide Hydrolase Inhibitor t-AUCB Modulates the Function of Endothelial Progenitor Cells from Patients with Acute Myocardial Infarction_x000D_ through PPARy.
Periodical: International Journal of Cardiology Index Medicus:
Authors: Xu DY, Davis BB, Zhao SP, Wang ZH, Wasti B, Liu ZL, Li N, Morisseau C, Chiamvimonvat N. ART
Yr: 2012 Vol: Nbr: Abs: Pg:

Leukocytes are recruited through the Bronchial Circulation to the Lung in a Spontaneously Hypertensive Rat Model of COPD.
Periodical: PLOS One Index Medicus:
Authors: Davis BB, Shen YH, Tancredi DJ, Flores V, Davis RP, Pinkerton KE. ART
Yr: 2012 Vol: Epub 2012 Nbr: Abs: Pg:

Soluble epoxide hydrolase inhibitors and cardiovascular diseases.
Periodical: Currrent Vascular Pharmacology Index Medicus:
Authors: Wang ZH, Davis BB, Ulu A, Jiang DJ, Zhao TT, Xu DY. ART
Yr: 2012 Vol: Nbr: Abs: Pg: